Abstract:
Type 2 diabetes mellitus (T2D) is a major non- infectious disease in the world and a
global concern. Diabetes is a condition of multifactorial origin, including genetic and
environmental factors. Further, scientific evidence suggests that increased
inflammatory stress related to molecular mechanisms leading to insulin resistance,
the intestinal microbiota interacting with environmental factors and susceptible
genetic factors contributes to the development of diabetes.
Soft drink consumption is a controversial issue for public health. Over the years,
numerous studies have been conducted to find the possible links between soft drink
intake and diabetes. As a result, increasing emphasis is being placed on the health
properties of soft drinks, which leads the production of functional drinks. Hence this
review appraises the current literature with the aim of producing a functional drink
with probiotic bacteria in order to control blood sugar and prevent type 2 diabetes.
Since the efficacy of probiotics is directly linked to the type of strain, the
identification of strains used in the intervention are most beneficial for patients with
T2D. The study suggested that the probiotics Lactobacillus acidophilus and
Bifidobacterium animalis may have health benefits in people with type 2 diabetes. A
study has shown daily consumption of 200 ml of a shake containing 4x108
CFU/100ml of Lactobacillus acidophilus, 4x108 CFU/100ml of Bifidobacterium
bifidum and 1 g/100 ml of fructooligosaccharides, resulted in blood glucose reduction
in diabetes patients. Probiotic bacteria, which is facultatively anaerobic and
microaerophilic is encapsulated and inoculated to the functional drink. Thus after
ingestion the probiotics become active in the existing optimal temperature around
37⁰C, tolerating the conditions of the gastrointestinal tract.
The evidence available from experimental studies and clinical trials supports our
suggestion that the modulation of the intestinal microbiota by probiotics in functional
drinks may be effective towards prevention and management of type 2 diabetes.
